Here are four points:
1. Under the research agreement, the two companies will create precision diagnostics for pathogens and their antimicrobial resistances in infectious diseases.
2. A biotech company, bioMérieux develops in vitro diagnostics for infectious diseases.
3. bioMérieux will team up with George Weinstock, PhD, who is a Jackson Laboratory professor, Evnin Family Chair and director of microbial genomics.
4. Dr. Weinstock’s laboratory is focused on next-generation DNA sequencing and metagenomic analysis.
More articles on quality & infection control:
FDA recommends all US blood donations should be screened for Zika — 5 highlights
Bringing caregivers into the fold: 5 strategies for nurses to improve the patient experience
Mylan to offer $300 generic to EpiPen auto-injector in effort to save face: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
